Cytokeratin 19 - Revision history

Michael: /* Positive */

2016-05-10T16:40:03Z

Positive

← Older revision		Revision as of 16:40, 10 May 2016
Line 2:		Line 2:

	==Positive==		==Positive==
			===Benign===
	*Thyroid.<ref name=pmid19956064>{{Cite journal \| last1 = Jain \| first1 = R. \| last2 = Fischer \| first2 = S. \| last3 = Serra \| first3 = S. \| last4 = Chetty \| first4 = R. \| title = The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. \| journal = Appl Immunohistochem Mol Morphol \| volume = 18 \| issue = 1 \| pages = 9-15 \| month = Jan \| year = 2010 \| doi = 10.1097/PAI.0b013e3181ad36ea \| PMID = 19956064 }}		*Thyroid.<ref name=pmid19956064>{{Cite journal \| last1 = Jain \| first1 = R. \| last2 = Fischer \| first2 = S. \| last3 = Serra \| first3 = S. \| last4 = Chetty \| first4 = R. \| title = The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. \| journal = Appl Immunohistochem Mol Morphol \| volume = 18 \| issue = 1 \| pages = 9-15 \| month = Jan \| year = 2010 \| doi = 10.1097/PAI.0b013e3181ad36ea \| PMID = 19956064 }}
	</ref>		</ref>
	*Gastrointestinal tract.<ref name=pmid19956064/>		*Gastrointestinal tract.<ref name=pmid19956064/>
	*Pancreas.<ref name=pmid19956064/>		*Pancreas.<ref name=pmid19956064/>
	*[[Cholangiocarcinoma]].
	*Salivary gland - marks luminal cells.		*Salivary gland - marks luminal cells.

			===Tumour/malignant===
	*[[Adamantinoma]].		*[[Adamantinoma]].
			*[[Cholangiocarcinoma]].
	*[[Yolk sac tumour]].<ref>{{Cite journal \| last1 = Bremmer \| first1 = F. \| last2 = Ströbel \| first2 = P. \| last3 = Hubertus \| first3 = H. \| last4 = Strecker \| first4 = J. \| last5 = Gaisa \| first5 = N. \| last6 = Strauß \| first6 = A. \| last7 = Schweyer \| first7 = S. \| last8 = Radzun \| first8 = H-J. \| last9 = Behnes \| first9 = C-L \| title = CK19 is a sensitive marker for yolk sac tumours of the testis. \| journal = Diagnostic Pathology \| volume = 10 \| issue = 7 \| pages = \| month = \| year = 2015 \| doi = 10.1186/s13000-015-0243-y \| PMID = \| url = www.diagnosticpathology.org/content/10/1/7‎Cached }}</ref>		*[[Yolk sac tumour]].<ref>{{Cite journal \| last1 = Bremmer \| first1 = F. \| last2 = Ströbel \| first2 = P. \| last3 = Hubertus \| first3 = H. \| last4 = Strecker \| first4 = J. \| last5 = Gaisa \| first5 = N. \| last6 = Strauß \| first6 = A. \| last7 = Schweyer \| first7 = S. \| last8 = Radzun \| first8 = H-J. \| last9 = Behnes \| first9 = C-L \| title = CK19 is a sensitive marker for yolk sac tumours of the testis. \| journal = Diagnostic Pathology \| volume = 10 \| issue = 7 \| pages = \| month = \| year = 2015 \| doi = 10.1186/s13000-015-0243-y \| PMID = \| url = www.diagnosticpathology.org/content/10/1/7‎Cached }}</ref>
	*Breast carcinoma - common (~91%).<ref name=pmid25453845/>		*[[Breast carcinoma]] - common (~91%).<ref name=pmid25453845/>
	*[[Lung adenocarcinoma]] (~95%).<ref name=pmid25453845>{{Cite journal \| last1 = Masai \| first1 = K. \| last2 = Nakagawa \| first2 = K. \| last3 = Yoshida \| first3 = A. \| last4 = Sakurai \| first4 = H. \| last5 = Watanabe \| first5 = S. \| last6 = Asamura \| first6 = H. \| last7 = Tsuta \| first7 = K. \| title = Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases. \| journal = Lung Cancer \| volume = 86 \| issue = 3 \| pages = 318-23 \| month = Dec \| year = 2014 \| doi = 10.1016/j.lungcan.2014.09.018 \| PMID = 25453845 }}</ref>		*[[Lung adenocarcinoma]] (~95%).<ref name=pmid25453845>{{Cite journal \| last1 = Masai \| first1 = K. \| last2 = Nakagawa \| first2 = K. \| last3 = Yoshida \| first3 = A. \| last4 = Sakurai \| first4 = H. \| last5 = Watanabe \| first5 = S. \| last6 = Asamura \| first6 = H. \| last7 = Tsuta \| first7 = K. \| title = Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases. \| journal = Lung Cancer \| volume = 86 \| issue = 3 \| pages = 318-23 \| month = Dec \| year = 2014 \| doi = 10.1016/j.lungcan.2014.09.018 \| PMID = 25453845 }}</ref>

Michael at 16:48, 9 May 2016

2016-05-09T16:48:08Z

← Older revision		Revision as of 16:48, 9 May 2016
Line 1:		Line 1:
	'''Cytokeratin 19''', abbreviated '''CK19''', is a commonly available keratin [[immunostain]].		'''Cytokeratin 19''', abbreviated '''CK19''', is a commonly available (low molecular weight) keratin [[immunostain]].<ref>{{Cite journal \| last1 = Yui \| first1 = T. \| last2 = Ohmachi \| first2 = T. \| last3 = Matsuda \| first3 = K. \| last4 = Okamoto \| first4 = M. \| last5 = Taniyama \| first5 = H. \| title = Histochemical and immunohistochemical characterization of chordoma in ferrets. \| journal = J Vet Med Sci \| volume = 77 \| issue = 4 \| pages = 467-73 \| month = Apr \| year = 2015 \| doi = 10.1292/jvms.14-0488 \| PMID = 25648567 }}</ref>

	==Positive==		==Positive==

Michael at 16:44, 9 May 2016

2016-05-09T16:44:48Z

← Older revision		Revision as of 16:44, 9 May 2016
Line 1:		Line 1:
	'''Cytokeratin 19''', abbreviated '''CK19''', is a commonly available keratin.		'''Cytokeratin 19''', abbreviated '''CK19''', is a commonly available keratin [[immunostain]].

	==Positive==		==Positive==

Michael at 21:40, 20 August 2015

2015-08-20T21:40:41Z

← Older revision		Revision as of 21:40, 20 August 2015
Line 10:		Line 10:
	*[[Adamantinoma]].		*[[Adamantinoma]].
	*[[Yolk sac tumour]].<ref>{{Cite journal \| last1 = Bremmer \| first1 = F. \| last2 = Ströbel \| first2 = P. \| last3 = Hubertus \| first3 = H. \| last4 = Strecker \| first4 = J. \| last5 = Gaisa \| first5 = N. \| last6 = Strauß \| first6 = A. \| last7 = Schweyer \| first7 = S. \| last8 = Radzun \| first8 = H-J. \| last9 = Behnes \| first9 = C-L \| title = CK19 is a sensitive marker for yolk sac tumours of the testis. \| journal = Diagnostic Pathology \| volume = 10 \| issue = 7 \| pages = \| month = \| year = 2015 \| doi = 10.1186/s13000-015-0243-y \| PMID = \| url = www.diagnosticpathology.org/content/10/1/7‎Cached }}</ref>		*[[Yolk sac tumour]].<ref>{{Cite journal \| last1 = Bremmer \| first1 = F. \| last2 = Ströbel \| first2 = P. \| last3 = Hubertus \| first3 = H. \| last4 = Strecker \| first4 = J. \| last5 = Gaisa \| first5 = N. \| last6 = Strauß \| first6 = A. \| last7 = Schweyer \| first7 = S. \| last8 = Radzun \| first8 = H-J. \| last9 = Behnes \| first9 = C-L \| title = CK19 is a sensitive marker for yolk sac tumours of the testis. \| journal = Diagnostic Pathology \| volume = 10 \| issue = 7 \| pages = \| month = \| year = 2015 \| doi = 10.1186/s13000-015-0243-y \| PMID = \| url = www.diagnosticpathology.org/content/10/1/7‎Cached }}</ref>
	*Breast carcinoma - common (~91%).<ref name=pmid25453845></~~ref~~>		*Breast carcinoma - common (~91%).<ref name=pmid25453845/>
	*[[Lung adenocarcinoma]] (~95%).<ref name=pmid25453845></ref>		*[[Lung adenocarcinoma]] (~95%).<ref name=pmid25453845>{{Cite journal \| last1 = Masai \| first1 = K. \| last2 = Nakagawa \| first2 = K. \| last3 = Yoshida \| first3 = A. \| last4 = Sakurai \| first4 = H. \| last5 = Watanabe \| first5 = S. \| last6 = Asamura \| first6 = H. \| last7 = Tsuta \| first7 = K. \| title = Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases. \| journal = Lung Cancer \| volume = 86 \| issue = 3 \| pages = 318-23 \| month = Dec \| year = 2014 \| doi = 10.1016/j.lungcan.2014.09.018 \| PMID = 25453845 }}</ref>

	==Negative==		==Negative==

Michael: /* Positive */

2015-08-20T21:40:06Z

Positive

← Older revision		Revision as of 21:40, 20 August 2015
Line 10:		Line 10:
	*[[Adamantinoma]].		*[[Adamantinoma]].
	*[[Yolk sac tumour]].<ref>{{Cite journal \| last1 = Bremmer \| first1 = F. \| last2 = Ströbel \| first2 = P. \| last3 = Hubertus \| first3 = H. \| last4 = Strecker \| first4 = J. \| last5 = Gaisa \| first5 = N. \| last6 = Strauß \| first6 = A. \| last7 = Schweyer \| first7 = S. \| last8 = Radzun \| first8 = H-J. \| last9 = Behnes \| first9 = C-L \| title = CK19 is a sensitive marker for yolk sac tumours of the testis. \| journal = Diagnostic Pathology \| volume = 10 \| issue = 7 \| pages = \| month = \| year = 2015 \| doi = 10.1186/s13000-015-0243-y \| PMID = \| url = www.diagnosticpathology.org/content/10/1/7‎Cached }}</ref>		*[[Yolk sac tumour]].<ref>{{Cite journal \| last1 = Bremmer \| first1 = F. \| last2 = Ströbel \| first2 = P. \| last3 = Hubertus \| first3 = H. \| last4 = Strecker \| first4 = J. \| last5 = Gaisa \| first5 = N. \| last6 = Strauß \| first6 = A. \| last7 = Schweyer \| first7 = S. \| last8 = Radzun \| first8 = H-J. \| last9 = Behnes \| first9 = C-L \| title = CK19 is a sensitive marker for yolk sac tumours of the testis. \| journal = Diagnostic Pathology \| volume = 10 \| issue = 7 \| pages = \| month = \| year = 2015 \| doi = 10.1186/s13000-015-0243-y \| PMID = \| url = www.diagnosticpathology.org/content/10/1/7‎Cached }}</ref>
			*Breast carcinoma - common (~91%).<ref name=pmid25453845></ref>
			*[[Lung adenocarcinoma]] (~95%).<ref name=pmid25453845></ref>

	==Negative==		==Negative==

Michael at 21:33, 20 August 2015

2015-08-20T21:33:40Z

← Older revision		Revision as of 21:33, 20 August 2015
Line 6:		Line 6:
	*Gastrointestinal tract.<ref name=pmid19956064/>		*Gastrointestinal tract.<ref name=pmid19956064/>
	*Pancreas.<ref name=pmid19956064/>		*Pancreas.<ref name=pmid19956064/>
			*[[Cholangiocarcinoma]].
			*Salivary gland - marks luminal cells.
			*[[Adamantinoma]].
			*[[Yolk sac tumour]].<ref>{{Cite journal \| last1 = Bremmer \| first1 = F. \| last2 = Ströbel \| first2 = P. \| last3 = Hubertus \| first3 = H. \| last4 = Strecker \| first4 = J. \| last5 = Gaisa \| first5 = N. \| last6 = Strauß \| first6 = A. \| last7 = Schweyer \| first7 = S. \| last8 = Radzun \| first8 = H-J. \| last9 = Behnes \| first9 = C-L \| title = CK19 is a sensitive marker for yolk sac tumours of the testis. \| journal = Diagnostic Pathology \| volume = 10 \| issue = 7 \| pages = \| month = \| year = 2015 \| doi = 10.1186/s13000-015-0243-y \| PMID = \| url = www.diagnosticpathology.org/content/10/1/7‎Cached }}</ref>

			==Negative==
			*[[Hepatocellular carcinoma]].

	==See also==		==See also==
Line 12:		Line 19:

	==References==		==References==
	{{Reflist\|1}}		{{Reflist\|2}}

	[[Category:Immunohistochemistry]]		[[Category:Immunohistochemistry]]

Michael: create

2015-08-20T21:27:52Z

create

New page

'''Cytokeratin 19''', abbreviated '''CK19''', is a commonly available keratin.

==Positive==
*Thyroid.<ref name=pmid19956064>{{Cite journal | last1 = Jain | first1 = R. | last2 = Fischer | first2 = S. | last3 = Serra | first3 = S. | last4 = Chetty | first4 = R. | title = The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. | journal = Appl Immunohistochem Mol Morphol | volume = 18 | issue = 1 | pages = 9-15 | month = Jan | year = 2010 | doi = 10.1097/PAI.0b013e3181ad36ea | PMID = 19956064 }}
</ref>
*Gastrointestinal tract.<ref name=pmid19956064/>
*Pancreas.<ref name=pmid19956064/>

==See also==
*[[CK7]].
*[[CK20]].

==References==
{{Reflist|1}}

[[Category:Immunohistochemistry]]